Dr. Kumanan Wilson

CEO and Chief Scientific Officer of the Bruyère Health Research Institute and Vice-President of Research and Academic Affairs

Kumanan is the CEO and Chief Scientific Officer of the Bruyère Health Research Institute and Vice-President of Research and Academic Affairs at Bruyère Health, where he also previously served as an innovation advisor.

His research focuses on digital health, health data, immunization, pandemic preparedness and public health policy and innovation.

Dr. Wilson is also a specialist in General Internal Medicine and a Distinguished Clinical Research Chair in Digital Health Innovation with the Department of Medicine at The Ottawa Hospital, and he is a Full Professor in the Faculty of Medicine at the University of Ottawa. He is the co-founder and Chief Scientific Officer of CANImmunize, a science-based technology company specializing in immunization software.

He has received support from multiple organizations including the Canadian Institutes of Health Research, the World Health Organization, The Bill & Melinda Gates Foundation and Canada’s Immunity Task Force.